Peptidomimetics with photocontrolled biological activity

Información del proyecto

PELICO

Identificador del acuerdo de subvención: 690973

DOI

10.3030/690973

Proyecto cerrado

Fecha de la firma de la CE 9 Diciembre 2015

Fecha de inicio 1 Enero 2016

Fecha de finalización 31 Diciembre 2019

Financiado con arreglo a

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Coste total

€ 688 500,00

Aportación de la UE

€ 688 500,00

Coordinado por

ENAMINE LIMITED LIABILITY COMPANY,RESEARCH AND PRODUCTION ENTERPRISE
Ukraine

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Other (1)

Novel photocontrollable building blocks

Novel photocontrollable building blocks (in the amount 100-1000 mg), with full characterization data

Websites, patent fillings, videos etc. (1)

Project web-site

Web-site reflecting the essence and non-confidential current results of the work under the Project

Documents, reports (5)

manuscript 4

manuscript of paper based on the obtained results (on novel “molecular photoswitches”)

Manuscript 1

Manuscript draft to be submitted to a peer-reviewed scientific journal containing the results of the in vivo studies which will be considered not confidential

Reports on biological activity studies

Reports on biological activity studies of the novel peptidomimetics

Manuscript 2

Manuscripts of papers based on the obtained results on the lead optimization

Manuscript 3

Manuscripts of a paper based on the obtained results (novel stapled peptidomimetics)

Publicaciones

Peer reviewed articles (6)

Flexibility vs rigidity of amphipathic peptide conjugates when interacting with lipid bilayers

Autores: Oleg Babii, Sergii Afonin, Tim Schober, Igor V. Komarov, Anne S. Ulrich
Publicado en: Biochimica et Biophysica Acta (BBA) - Biomembranes, Edición 1859/12, 2017, Página(s) 2505-2515, ISSN 0005-2736
Editor: Elsevier BV
DOI: 10.1016/j.bbamem.2017.09.021

Highly reactive bis-cyclooctyne-modified diarylethene for SPAAC-mediated cross-linking

Autores: Alexander V. Strizhak, Krishna Sharma, Oleg Babii, Sergii Afonin, Anne S. Ulrich, Igor V. Komarov, David R. Spring
Publicado en: Organic & Biomolecular Chemistry, 2018, ISSN 1477-0520
Editor: Royal Society of Chemistry
DOI: 10.1039/c8ob02428f

Structure–Activity Relationships of Photoswitchable Diarylethene-Based β-Hairpin Peptides as Membranolytic Antimicrobial and Anticancer Agents

Autores: Oleg Babii, Sergii Afonin, Aleksandr Yu. Ishchenko, Tim Schober, Anatoliy O. Negelia, Ganna M. Tolstanova, Liudmyla V. Garmanchuk, Liudmyla I. Ostapchenko, Igor V. Komarov, Anne S. Ulrich
Publicado en: Journal of Medicinal Chemistry, Edición 61/23, 2018, Página(s) 10793-10813, ISSN 0022-2623
Editor: American Chemical Society
DOI: 10.1021/acs.jmedchem.8b01428

Controlling the Uptake of Diarylethene‐Based Cell‐Penetrating Peptides into Cells Using Light

Autores: Tim Schober, Ilona Wehl, Sergii Afonin, Oleg Babii, Anna Iampolska, Ute Schepers, Igor V. Komarov, Anne S. Ulrich
Publicado en: ChemPhotoChem, 2019, ISSN 2367-0932
Editor: Wiley-VCH Verlag GmbH & Co. KGaA
DOI: 10.1002/cptc.201900019

Light-controllable dithienylethene-modified cyclic peptides: photoswitching the in vivo toxicity in zebrafish embryos

Autores: Sergii Afonin, Oleg Babii, Aline Reuter, Volker Middel, Masanari Takamiya, Uwe Strähle, Igor V Komarov, Anne S Ulrich
Publicado en: Beilstein Journal of Organic Chemistry, Edición 16, 2020, Página(s) 39-49, ISSN 1860-5397
Editor: Beilstein-Institut
DOI: 10.3762/bjoc.16.6

Peptide drugs for photopharmacology: how much of a safety advantage can be gained by photocontrol?

Autores: Oleg Babii, Sergii Afonin, Tim Schober, Liudmyla V Garmanchuk, Liudmyla I Ostapchenko, Volodymyr Yurchenko, Sergey Zozulya, Oleksandr Tarasov, Iryna Pishel, Anne S Ulrich, Igor V Komarov
Publicado en: Future Drug Discovery, 2020, ISSN 2631-3316
Editor: Future Science
DOI: 10.4155/fdd-2019-0033